	Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma. FEBS J Katsoulieris EN, Ioannou P, Afratis NA. PMID: 41506657 [PubMed - as supplied by publisher]
	Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance). Cancer Immunol Res Liu A, Johnson C, Niedzwiecki D, Relation T, Yarlagadda S, Gajewski TF, Carson WE. PMID: 41505731 [PubMed - as supplied by publisher]
	Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma. J Cancer Res Clin Oncol Oksuz S, Kinikoglu O, Ozkerim U, Isik D, Surmeli H, Ay S, Gundogdu UD, Basoglu T, Odabas H, Turan N. PMID: 41504775 [PubMed - indexed for MEDLINE]
	Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol. Exp Dermatol Fujimura T, Yoshino K, Kato H, Fukushima S, Fujisawa Y, Matsushita S, Uhara H, Rokunohe D, Takenouchi T, Maekawa T, Nakamura Y, Namikawa K, Takahashi A, Yoshikawa S, Iwata H, Yamasaki O, Uchi H, Ohno F, Ito T, Tanemura A, Ohe S, Yamazaki E, Takahashi-Watanabe M, Muto Y, Kambayashi Y, Hashimoto A, Asano Y. PMID: 41504650 [PubMed - indexed for MEDLINE]
	LCSD-Net: a light-weight cross-attention-based semantic dual transformer for domain generalization in melanoma detection. J Med Imaging (Bellingham) Agrawal R, Gupta N, Jalal AS. PMID: 41503367 [PubMed]
	Acral Lentiginous Melanoma of the Hand: Diagnostic Pitfalls and Margin Management Strategies. Plast Reconstr Surg Glob Open Abella M, Kuschner S, Krajisnik A, Amersi F, Kulber D. PMID: 41503202 [PubMed]
	Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study. Eur J Cancer Helgadottir H, Ny L, Ullenhag GJ, Mikiver R, Isaksson K, Olofsson Bagge R. PMID: 41500895 [PubMed - as supplied by publisher]
	Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma. BMJ Open Ophthalmol Murtagh P, O'Riordan MM, O'Neill V, Cunningham M, D'Arcy F, Eleuteri A, Greene A, Baily C, Kennedy S, Hussain R, Heimann H, Horgan N. PMID: 41500613 [PubMed - indexed for MEDLINE]
	Oncologic and Surgical Outcomes of Head and Neck Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis of Wide Local Excision Versus Mohs Micrographic Surgery. J Cutan Med Surg Nukaly HY, Alghamdi AM, Aljohani AG, Almaghrabi M, Aljuhani JA, Alqazenli M, Ezzi S, Barnawi G, Alturkistani T, Jfri A, Litvinov IV. PMID: 41499252 [PubMed - as supplied by publisher]
	Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study. J Dermatol Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. PMID: 41496663 [PubMed - as supplied by publisher]
	Melanoma: Pathogenesis and Targeted Therapy. MedComm (2020) Fu Y, Liu J, Mo Z, Wang B, Deng Y, Jiang Y. PMID: 41492362 [PubMed]
	Effectiveness of telemedicine interventions in the care management of melanoma: a systematic review. Inform Health Soc Care Nopour R. PMID: 41491400 [PubMed - as supplied by publisher]
	Outcome of Ruthenium-106 Brachytherapy for Uveal Melanoma and Retinal Vascular Tumors: A Retrospective Study. J Curr Ophthalmol Karimi S, Ashrafi S, Hosseini Imeni SM, Siavashpour Z. PMID: 41488719 [PubMed]
	Surgical treatment of vaginal and vulvar melanoma: a 18-year retrospective study. Eur J Surg Oncol Dabreteau T, Maulard A, El Hajj H, Robert C, Genestie C, Pautier P, Morice P, Gouy S. PMID: 41485272 [PubMed - as supplied by publisher]
	Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial. JAMA Oncol Sheng X, Huang G, Fang M, Li K, Wu D, Zhang X, Chen J, Zhu D, Chen Y, Li H, Gao Q, Wu L, Tang B, Yan X, Zeng R, Li J, Yu W, Xu J, Hao Y, Jin C, Zou J, Guo J. PMID: 41481311 [PubMed - as supplied by publisher]
	Oral contraceptive use and risk of melanoma in a large cohort of Dutch nurses. Int J Epidemiol De Bruijn L, Van Duijne HM, Berentzen NE, Vermeulen RCH, Vlaanderen JJ, Kromhout H, Jó, Van Leeuwen FE, Schaapveld M. PMID: 41481240 [PubMed - indexed for MEDLINE]
	Phase II trial on nivolumab plus hypofractionated radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial. Immunooncol Technol Nomura M, Yoshimura M, Yokota T, Boku S, Oze I, Ishikawa H, Muto M. PMID: 41477574 [PubMed]
	Standardized Incidence Ratio of Melanoma by Industry Groups in Korea. Saf Health Work Kim K, Lee WR, Lee W, Han KT, Yoo KB, Yoon JH. PMID: 41477044 [PubMed]
	Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients. Front Immunol Thielmann CM, Seier JA, Schielke L, Albrecht LJ, Zimmer L, Livingstone E, Zaremba A, Lodde G, Dissemond J, Sondermann W, Krefting F, Tasdogan A, Roesch A, Hadaschik E, Rambow F, Griewank K, Ugurel S, Schadendorf D, Placke JM. PMID: 41476990 [PubMed - indexed for MEDLINE]
	4-year overall survival after the introduction of adjuvant therapy for patients with stage III melanoma: A population-based study. Eur J Cancer Janssen JC, Schurink AW, Verhoef C, Oomen-de Hoop E, Louwman MWJ, Grünhagen DJ, van der Veldt AAM. PMID: 41475996 [PubMed - as supplied by publisher]

Articles 1 - 20 / 44772

Page 1 of 2239



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy